Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ghislain, Bouda"'
Autor:
Haoua Tall, Pierrick Adam, Abdoul Salam Eric Tiendrebeogo, Jeanne Perpétue Vincent, Laura Schaeffer, Cassandre von Platen, Sandrine Fernandes-Pellerin, François Sawadogo, Alkadri Bokoum, Ghislain Bouda, Seydou Ouattara, Issa Ouédraogo, Magali Herrant, Pauline Boucheron, Appolinaire Sawadogo, Edouard Betsem, Alima Essoh, Lassané Kabore, Amariane Ouattara, Nicolas Méda, Hervé Hien, Andréa Gosset, Tamara Giles-Vernick, Sylvie Boyer, Dramane Kania, Muriel Vray, Yusuke Shimakawa
Publikováno v:
Vaccines, Vol 9, Iss 6, p 583 (2021)
To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Since 2009, the WHO has recommended administering hepatitis B vaccine to all neonates within 24 h of birth
Externí odkaz:
https://doaj.org/article/5b556f5ede7f4692a2a5adb70ec9a2c8
Mobile Monitoring of Diabetic Patients in the Active File of the Medical Center of Do (Burkina Faso)
Autor:
Bry, Sylla, Seydou Golo, Barro, Jeoffray, Diendere, Rachid G, Konfe, Ghislain, Bouda, Pascal, Staccini
Publikováno v:
Studies in health technology and informatics. 289
The care of diabetic patients in peripheral medical centers in Burkina Faso faces many difficulties. This work, which is a new experience, aimed to set up an information system for the care of diabetic patients in the context of Burkina Faso. The sys
Mobile Monitoring of Diabetic Patients in the Active File of the Medical Center of Do (Burkina Faso)
Autor:
Bry Sylla, Seydou Golo Barro, Jeoffray Diendere, Rachid G. Konfe, Ghislain Bouda, Pascal Staccini
The care of diabetic patients in peripheral medical centers in Burkina Faso faces many difficulties. This work, which is a new experience, aimed to set up an information system for the care of diabetic patients in the context of Burkina Faso. The sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0a141f0cc87b0d9b63b2392b257aaf0
https://doi.org/10.3233/shti210881
https://doi.org/10.3233/shti210881
Autor:
François Sawadogo, A. Sawadogo, Andréa Gosset, Alima T. Essoh, Dramane Kania, Lassané Kabore, Tamara Giles-Vernick, Yusuke Shimakawa, Nicolas Meda, Cassandre Von Platen, Pierrick Adam, Issa Ouedraogo, Alkadri Bokoum, Muriel Vray, Sandrine Fernandes-Pellerin, Magali Herrant, Amariane Ouattara, Ghislain Bouda, Haoua Tall, Laura Schaeffer, Hervé Hien, Jeanne Perpétue Vincent, Edouard Betsem, Pauline Boucheron, Seydou Ouattara, Sylvie Boyer, Abdoul Salam Eric Tiendrebeogo
Publikováno v:
Vaccines
Vaccines, 2021, 9 (6), pp.583. ⟨10.3390/vaccines9060583⟩
Vaccines, Vol 9, Iss 583, p 583 (2021)
Vaccines, MDPI, 2021, 9 (6), pp.583. ⟨10.3390/vaccines9060583⟩
Volume 9
Issue 6
Vaccines, 2021, 9 (6), pp.583. ⟨10.3390/vaccines9060583⟩
Vaccines, Vol 9, Iss 583, p 583 (2021)
Vaccines, MDPI, 2021, 9 (6), pp.583. ⟨10.3390/vaccines9060583⟩
Volume 9
Issue 6
International audience; To achieve global hepatitis elimination by 2030, it is critical to prevent the mother-to-child transmission (MTCT) of hepatitis B virus (HBV). Since 2009, the WHO has recommended administering hepatitis B vaccine to all neonat